ANTI-ERBB2-ANTIKÖRPERVARIANTEN

Patent europeic · EP2847227 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2847227
Numer da la dumonda
EP13788202
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
26-04-2013
Publitgà
18-03-2015
Concedì
16-08-2017
Stritgà
23-11-2022
Motiv
Taxa annuala betg pajada
Classas IPC
C07K 16/30 (2006.01)
C12N 15/13 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
Prioritad
KR 20120048805 08.05.2012
Dumonda PCT
PCT/KR2013/003635 26.04.2013
Publicaziun PCT
WO2013/168918 14.11.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-11-2022

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.11.2022

  2. 07-10-2017

    Represchentant inscrit

    Representative
    BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 07.10.2017

  3. 16-08-2017

    Concedì

    Published in Swissreg on 16.08.2017

Partidas

Possessur

Chong Kun Dang Pharmaceutical Corp.

(Chungjeongno 3-ga Chong Kun Dang Building) 8, Chungjeong-ro Seodaemun-gu, Seoul 120-726, KR

Represchentant

Bovard AG

BOVARD AG Patent- und Markenanwälte

Optingenstrasse 16, 3013 Bern

Inventur

MOON, Seung-Kee

Yongin-si Gyeonggi-do 446-916, KR

PARK, So-Ra

Yongin-si Gyeonggi-do 446-916, KR

AN, Ki-Young

Yongin-si Gyeonggi-do 446-916, KR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.